Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt.Likely | 18 | - |
| 2 | Schedule 2 | Not yet disclosed by govt.Likely | 18 | - |
| 3 | Schedule 3 | R.P.S.PHARMALikely | 1 | ₹65,880 |
| 4 | Schedule 5 | Not yet disclosed by govt.Likely | 18 | - |
| 5 | Schedule 6 | R & R SURGI HUBLikely | 2 | ₹25,704 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
10 Jul 2025, 2:00 pmClosed
INDAPAMIDE SR 1 point 5 MG TAB NATRILEX
INJ DARBEPOETIN 60 MG
INJ PEGYLATED RECOMBINANT HUMAN ERYTHROPOIETIN
INJ RABIPUR VACCINE 1 ML
INJ ZOLEDRONIC ACID 5 MG
KIT FOR ESTIMATION OF BILIRUBIN
KIT FOR ESTIMATION OF GLUCOSE
KIT FOR ESTIMATION OF HDL
KIT FOR ESTIMATION OF TRIGLYCERIDE
KIT FOR ESTIMATION OF URIC ACID
LENALIDOMIDE 10 MG TAB
LENALIDOMIDE 5 MG CAP
LENVATINIB 4MG TAB
LEVODOPA 100MG point CARBIDOPA
LEVODOPA 200 MG CARBIDOPA 50 MG CR TAB
LITHIUM CARBONATE 300 MG CAP or TAB
MEMANTINE 5MG TAB
METHOTREXATE 2 point 5 MG TAB
METHOTREXATE 5MG TAB
METHYLCOBALAMIN 1500 MG TAB
METHYLCOBALAMIN 500MG TAB
METHYLPREDNISOLONE 4MG TAB
MICRO TIPS 50 to 200 UL PKT OF 1000
MIDODRINE 2 point 5 MG TAB
MONTELUKAST MONTAIR 10 MG TAB
NEBIVOLOL 5 MG TAB
NIFEDIPINE RETARD 20 MG CAP or TAB
NINTEDANIB 150 MG CAP
OLMESARTAN 40 MG TAB
ONDANSETRON 8 MG TAB
PANTAPROZOLE 40 MG point DOMPERIDONE
PANTOPRAZOLE 40MG point ITOPRIDE 150MG CAP
PANTOPRAZOLE 40 MG point DOMPERIDONE SR 30 MG CAP
PAROXETIN 25 MG TAB
POMALIDOMIDE 1 MG TAB
PRASUGREL 10 MG TAB
PRAZOSIN SR 5 MG TAB
PREDNISOLONE 10MG TAB
PROCHLORPERAZINE MALEATE 5 MG TAB STEMETIL
PYRIDOSTIGMINE 60 MG TAB
QUETIAPINE 25 MG TAB
QUETIAPINE SR 100 MG TAB
RABEPRAZOLE 20 MG TAB
RABEPRAZOLE 20MG point DOMEPERIDON 10MG TAB
RIFAXIMINE 400MG TAB
RISPERIDONE 2 MG TAB
ROSUVASTATIN 10 MG TAB
ROTACAP SALMETEROL 50 MCG point FLUTICASONE 250 MCG Bid Number : GEM/2025/B/6301502 Dated : 18-06-2025 Bid Document 1/40
7918853
GEM/2025/B/6301502
Two Packet Bid
INDAPAMIDE SR 1 point 5 MG TAB NATRILEX
35 days
Punjab; Jalandhar
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹25 L
₹50 L
80%
Exempted
11 Jul 2025
18 Jun 2025
10 Jul 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | INDAPAMIDE SR 1 point 5 MG TAB NATRILEX | INDAPAMIDE SR 1 point 5 MG TAB NATRILEX | 81,060 | No | JALANDHAR CITY | 28 |
| 2 | INJ DARBEPOETIN 60 MG | INJ DARBEPOETIN 60 MG | 18 | PFS | JALANDHAR CITY | 28 |
| 3 | INJ PEGYLATED RECOMBINANT HUMAN ERYTHROPOIETIN | INJ PEGYLATED RECOMBINANT HUMAN ERYTHROPOIETIN 75MCG | 12 | PFS | JALANDHAR CITY | 28 |
| 4 | INJ RABIPUR VACCINE 1 ML | INJ RABIPUR VACCINE 1 ML | 456 | AMP | JALANDHAR CITY | 28 |
| 5 | INJ ZOLEDRONIC ACID 5 MG | INJ ZOLEDRONIC ACID 5 MG | 24 | VIAL | JALANDHAR CITY | 28 |
| 6 | KIT FOR ESTIMATION OF BILIRUBIN | KIT FOR ESTIMATION OF BILIRUBIN | 102 | KIT | JALANDHAR CITY | 28 |
| 7 | KIT FOR ESTIMATION OF GLUCOSE | KIT FOR ESTIMATION OF GLUCOSE | 150 | KIT | JALANDHAR CITY | 28 |
| 8 | KIT FOR ESTIMATION OF HDL | KIT FOR ESTIMATION OF HDL | 129 | KIT | JALANDHAR CITY | 28 |
| 9 | KIT FOR ESTIMATION OF TRIGLYCERIDE | KIT FOR ESTIMATION OF TRIGLYCERIDE | 193 | KIT | JALANDHAR CITY | 28 |
| 10 | KIT FOR ESTIMATION OF URIC ACID | KIT FOR ESTIMATION OF URIC ACID | 198 | KIT | JALANDHAR CITY | 28 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7918853.pdf
GEM_BID
doc_pic_15_2025-06-02-18-01-22_18fccef26368be39ec54e7afcc03a57d.pdf
BOQ
boq_item_sample_file_2025-06-02-18-01-22_7bfcf118b5bfc7ad67cfa423448723ac.csv
BOQ
ATC_ca87062f-2192-46c5-bd9f1748868600648_USINGH1972.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .